Jill E. Hochlowski

AbbVie (United States)

Papers

1

Total Citations

36

H-Index

1

About

Jill E. Hochlowski is a leading figure in pharmaceutical process chemistry, best known for her pioneering work in automated synthesis and high-throughput purification. Her research focuses on accelerating drug discovery through integrated platforms that combine flow chemistry, purification, and sample management. Her most cited work, "An Automated Synthesis–Purification–Sample-Management Platform for the Accelerated Generation of Pharmaceutical Candidates" (2013, 36 citations), describes a groundbreaking system centered on a Mitsubishi robot that seamlessly links synthesis and purification steps. This innovation dramatically reduces the time required to generate small-molecule drug candidates, enabling faster iteration in medicinal chemistry. Hochlowski’s contributions have directly impacted how pharmaceutical companies approach compound generation, bridging the gap between laboratory-scale synthesis and scalable production. Her work exemplifies the integration of robotics and flow chemistry to solve real-world bottlenecks in drug development, making her a key figure in modern process chemistry.

Research Focus

Key Achievements

1
H-Index
1
Papers
36
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
An Automated Synthesis–Purification–Sample-Management Platform for the Accelerated Generation of Pharmaceutical Candidates
36 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: AbbVie (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago